Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05947266 · ClinicalTrials.gov registry record · NA
Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes
A NA study of HIV Infection Primary, sponsored by Florida International University.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT05947266: Recruiting NA study of HIV Infection Primary, sponsored by Florida International University.
NCT05947266 is a NA study of HIV Infection Primary that is actively recruiting participants, run by Florida International University. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05947266, a NA study of HIV Infection Primary, is actively recruiting participants, sponsored by Florida International University.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test a culturally tailored engagement and retention intervention for Haitian Immigrants Living With HIV (HILWH). The main questions it aims to answer are: * Does this intervention result in measurable engagement and retention in care? * Does this intervention result in measurable viral suppression within 6 months? Participants will * participate in a pilot health intervention entailing 4 individual meetings, approximately once monthly over a six-month period and completing research questionnaires at enrollment, post-intervention and at 6 months post-enrollment. * Six participants who have completed the pilot intervention and agree to take part, will participate in the photovoice portion of the study. This activity will consist of 6 additional meetings where participants will be taught about using photographs to illustrate their experience participating in the study and take and display photographs.
Primary Outcome
Change in Engagement in Care score over time, including comfort and communication with provider
Conditions Studied
Interventions
- BEHAVIORAL an adaptation of the iENGAGE
Study Locations (1)
Florida
- Care Resource, Inc. - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05947266 shows while recruiting
NCT05947266 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with HIV Infection Primary appearing as the primary indexed condition, and to 1 intervention - of which an adaptation of the iENGAGE is the first listed.
NCT05947266 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05947266 about?
NCT05947266 is a clinical study titled "Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes". The goal of this clinical trial is to test a culturally tailored engagement and retention intervention for Haitian Immigrants Living With HIV (HILWH). The main questions it aims to answer are: * Does this intervention result in measurable engagement and retention in care? * Does this intervention r...
What is the current status of trial NCT05947266?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2024-06-03. Estimated completion is 2026-06-30.
What conditions does trial NCT05947266 study?
This clinical trial studies the following conditions: HIV Infection Primary.
What interventions are being tested in trial NCT05947266?
The interventions under investigation include: an adaptation of the iENGAGE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05947266?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05947266 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection Primary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05947266's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI